Who are Aidoc's decision-makers?
Aidoc is led by Elad Walach, Co-founder and CEO, with a leadership bench spanning product, science, operations, and commercialization.
- CEO
- Elad Walach
- Key exec
- Michael Braginsky
- Founded
- 2016
- Employees
- Private; reports describe hundreds of employees
- HQ
- Tel Aviv, Israel
- Notable
- Leads company strategy and clinical AI commercialization.
- Elad WalachCo-founder and CEOCo-founder · since 2016Leads company strategy and clinical AI commercialization.
- Michael BraginskyCo-founder and CTOCo-founder · since 2016Leads technology and product architecture.
- Guy ReinerCo-founderCo-founder · since 2016Founding executive focused on clinical AI.
Who leads Aidoc?
Elad Walach serves as Co-founder and CEO; Michael Braginsky serves as Co-founder and CTO; Guy Reiner serves as Co-founder. The leadership pattern reflects the company's focus on clinical imaging ai.
For outreach, leadership background matters because it shows whether decisions are likely to be product-led, science-led, clinical, industrial, or government-procurement heavy.
Who actually makes buying decisions at Aidoc?
Likely buying committees include the executive owner of aiOS platform, security and compliance leaders, finance/procurement, and the technical leaders responsible for integration.
A seller should avoid starting with a generic CEO pitch unless the offer is strategic. Most practical deals will need a functional champion who owns deployment pain and a finance or operations approver.
How is Aidoc organized as it scales?
Aidoc's public footprint suggests a scaling private company with cross-functional teams around product, engineering, customer deployment, and go-to-market or R&D. Exact reporting lines are not public.
The safest assumption is a matrixed buying process: technical validation first, operational proof second, and executive approval for larger commitments.
As of June 2026.Sources:Aidoc websiteAxios Aidoc Series E coverage
Aidoc — frequently asked questions
